PCN153 Using a Budget IMPACT MODEL (BIM) As a Decision-Making Tool at the Hospital LEVEL in France: An Example of CPX-351 in Patients with NEWLY Diagnosed Therapy-Related AML (T-AML) or AML with Myelodysplasia-Related Changes (AML-MRC)

Autor:	R. Monnier, M. Pawlak, G. Guindeuil, S. Bourguignon
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Therapy related business.industry Health Policy Internal medicine Public Health Environmental and Occupational Health medicine Hospital level In patient Newly diagnosed Budget impact business
Zdroj:	Value in Health. 23:S450
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.290
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::22b75012f74c40e7e1aed4f1b21e654b https://doi.org/10.1016/j.jval.2020.08.290 Zobrazit plný text záznamu Full Text from ScienceDirect